HHR launched Haramaya University’s first-ever clinical trial, ECHiLiBRiST (Enhancing Children’s Life using Biomarkers for Risk Stratification and Triage), at Hiwot Fana Comprehensive Specialized Hospital. The study is designed to.
HHR’s Maternal Immunization Study team participated in the 2nd Annual Maternal Immunization Network in Africa and Asia (MIRINA) meeting, which was...
Dr. Barbara Mahon, Deputy Director of Surveillance and Epidemiology at the Bill & Melinda Gates Foundation, visited HHR. During her visit, Dr...
